{"slideshow_credits": null, "snippet": "The drug, Surfaxin, which helps premature babies with their breathing, won approval on its fifth try.", "abstract": "Discovery Laboratories wins Food and Drug Administration approval for the drug Surfaxin, used for the prevention of respiratory distress syndrome, a potentially fatal breathing disorder affecting premature babies; approval comes on the pharmaceutical company's fifth try, going back to 2004.", "section_name": "Health", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/03/07/health/policy/fda-backs-surfaxin-respiratory-distress-drug-for-babies.html", "lead_paragraph": "The drug, Surfaxin, which helps premature babies with their breathing, won approval on its fifth try.", "headline": {"seo": "F.D.A. Backs Respiratory Distress Drug For Babies", "main": "F.D.A. Backs Respiratory Distress Drug for Babies", "print_headline": "F.D.A. Backs Respiratory Distress Drug For Babies"}, "_id": "53f4561f38f0d857ea2d0ed2", "word_count": "418", "multimedia": [], "pub_date": "2012-03-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Premature Babies", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Respiratory Diseases", "name": "subject", "is_major": "Y", "rank": "5"}, {"value": "Discovery Laboratories", "name": "organizations", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": "Money & Policy", "type_of_material": "News"}